Impairment of neuronal activity occurs at the early stages of the aggregation cascade of Aβ1-42 and mutant Tau
Disease Models & Mechanisms · 2026
DOI: 10.1242/dmm.052295 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease Models & Mechanisms, 2026. Verfasst von Franziska Hirsch und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, University of Bremen, Leobener Strasse 2, 28359 Bremen, Germany. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, tau Proteins, Neurons, Mutation. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, MRF_, Alzheimer's Research UK.
Abstract (Originalsprache)
Alzheimer's disease (AD) is a progressive neurodegenerative disease that is characterized by the accumulation of amyloid-β (Aβ) plaques and neurofibrillary Tau tangles, ultimately leading to brain atrophy and death. To elucidate the relationship between the aberrant folding and aggregation of Aβ and mutant Tau and neuronal function, we monitored neuronal activity in C. elegans AD models across age. For that we used a neuronal GCaMP reporter to monitor fluctuations in Ca2+ and developed microfluidic devices to immobilize nematodes to non-invasively assess neuronal activity. Our findings reveal that expression of both Aβ and Tau lead to significant reductions in neuronal activity and function in young adult animals preceding the accumulation of amyloid aggregates. Notably, Aβ expression and aggregation in muscle tissue produced comparable detrimental effects on neuronal activity as its expression in neurons, suggesting that proteotoxic stress in muscle can influence neuronal function. This may occur through the propagation of Aβ from muscle to neurons or through retrograde signaling pathways. Further, our new sub-stoichiometrically labeled Tau strains highlight that TauP301L,V337M has a significant impact on neuronal activity throughout aging. These results enhance our understanding of the early functional effects of amyloid aggregation in Alzheimer's disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology, University of Bremen, Leobener Strasse 2, 28359 Bremen, Germany.
- Molecular Neuroscience Group, Department of Chemical Engineering and Biotechnology, University of Cambridge, Philippa-Fawcett Drive, Cambridge CB3 0AS, UK.
- Leibniz Institute on Aging - Fritz-Lipmann-Institute, Beutenbergstrasse 11, 07745 Jena, Germany.
- Friedrich-Schiller-Universität, Institute for Biochemistry & Biophysics, Hans Knöll-Strasse 2, 07745 Jena, Germany.
ORCID-Profile: Janine Kirstein
Förderung
- Deutsche Forschungsgemeinschaft
- MRF_
- Alzheimer's Research UK
- Alzheimer Forschung Initiative
- Universität Bremen
- Wellcome Trust
- Medical Research Council (MRC)
- Alzheimer Research UK (ARUK)
Zitieren
APA
Hirsch, F., F Läubli, N., Kelkar, A., Sleiman, M., Woitzat, Y., Gallrein, C., Gumz, V., Kalsi, G. K., Fernandez-Villegas, A., Schierle, G. S. K., & Kirstein, J. (2026). Impairment of neuronal activity occurs at the early stages of the aggregation cascade of Aβ1-42 and mutant Tau. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.052295
Vancouver
Hirsch F, F Läubli N, Kelkar A, Sleiman M, Woitzat Y, Gallrein C, et al. Impairment of neuronal activity occurs at the early stages of the aggregation cascade of Aβ1-42 and mutant Tau. Disease Models & Mechanisms. 2026. doi:10.1242/dmm.052295
BibTeX
@article{Hirsch2026,
author = {Hirsch, Franziska and F Läubli, Nino and Kelkar, Anushree and Sleiman, Mira and Woitzat, Yvonne and Gallrein, Christian and Gumz, Vanessa and Kalsi, Gurleen Kaur and Fernandez-Villegas, Ana and Schierle, Gabriele S Kaminski and Kirstein, Janine},
title = {Impairment of neuronal activity occurs at the early stages of the aggregation cascade of Aβ1-42 and mutant Tau},
journal = {Disease Models & Mechanisms},
year = {2026},
doi = {10.1242/dmm.052295}
}
EUVIMED